bHLH-PAS proteins in cancer
The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Mammalian basic HLH (helix-loop-helix)-PER-ARNT-SIM (bHLH-PAS) proteins are heterodimeric transcription factors that sense and respond to environmental signals (such as pollutants) or to physiological signals (for example, hypoxia and circadian rhythms) through their two PAS domains. PAS domains form a generic three-dimensional fold, which commonly contains an internal cavity capable of small-molecule binding and outer surfaces adept at protein-protein interactions. These proteins are important in several pro-tumour and antitumour pathways and their activities can be modulated by both natural metabolites and oncometabolites. Recently determined structures and successful small-molecule screening programmes are now providing new opportunities to discover selective agonists and antagonists directed against this multitasking family of transcription factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Each HIF transcription factor is composed of two subunits: the α-subunit and the β-subunit, both of which belong to the basic helix-loop-helix (HLH)-PER-ARNT-SIM (bHLH-PAS) protein family (Bersten et al., 2013).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Bersten et al., 2013
In the citing paper
“The reliability of the model derived from this template is supported by the observation that the PAS fold is highly conserved, especially among the bHLH-PAS proteins which also share functional similarities2,33 (RMSD on Cα lower than 2 Å even between PAS domain pairs with 20–30% identity).”
From Modeling the binding of diverse ligands within the Ah receptor ligand binding domain (2019) · cites this paper as [2]
Citations
Cites
1 retracted
RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
RetractedThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Preitner, N., Damiola, F., Luis-Lopez-Molina, Zakany, J., Duboule, D., Albrecht, U., & Schibler, U. (2002) · Cell · doi:10.1016/s0092-8674(02)00825-5 · Cited by 2,198
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53
Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
PAS Domains: Internal Sensors of Oxygen, Redox Potential, and Light
Taylor, B. L., & Zhulin, I. B. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.2.479-506.1999 · Cited by 1,632
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Self-citationExome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Barbieri, C. E., Baca, S. C., Lawrence, M. S., Demichelis, F., Blattner, M., Theurillat, J.-P., White, T. A., Stojanov, P., Van Allen, E., Stransky, N., et al. (2012) · Nature Genetics · doi:10.1038/ng.2279 · Cited by 1,558
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550
Self-citationChen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,465
Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., Guarente, L. P., & Sassone-Corsi, P. (2008) · Cell · doi:10.1016/j.cell.2008.07.002 · Cited by 1,427
SIRT1 regulates circadian clock gene expression through PER2 deacetylation
Asher, G., Gatfield, D., Stratmann, M., Reinke, H., Dibner, C., Kreppel, F., Mostoslavsky, R., Alt, F. W., & Schibler, U. (2008) · Cell · doi:10.1016/j.cell.2008.06.050 · Cited by 1,376
Interacting molecular loops in the mammalian circadian clock
Shearman, L. P., Sriram, S., Weaver, D. R., Maywood, E. S., Chaves, I., Zheng, B., Kume, K., Lee, C. C., van der, G. T. J., Horst, et al. (2000) · Science · doi:10.1126/science.288.5468.1013 · Cited by 1,367
Fu, L., Pelicano, H., Liu, J., Huang, P., & Lee, C. C. (2002) · Cell · doi:10.1016/s0092-8674(02)00961-3 · Cited by 1,270
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Onate, S. A., Tsai, S. Y., Tsai, M.-J., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,243
The genomic complexity of primary human prostate cancer
Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,234
Circadian Control of the NAD + Salvage Pathway by CLOCK-SIRT1
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P. (2009) · Science · doi:10.1126/science.1170803 · Cited by 1,198
Posttranslational Mechanisms Regulate the Mammalian Circadian Clock
Lee, C., Etchegaray, J.-P., Cagampang, F. R. A., Loudon, A. S. I., & Reppert, S. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00610-9 · Cited by 1,160
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD + Biosynthesis
Ramsey, K. M., Yoshino, J., Brace, C. S., Abrassart, D., Kobayashi, Y., Marcheva, B., Hong, H.-K., Chong, J. L., Buhr, E. D., Lee, C., et al. (2009) · Science · doi:10.1126/science.1171641 · Cited by 1,126
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119
A Functional Genomics Strategy Reveals Rora as a Component of the Mammalian Circadian Clock
Sato, T. K., Panda, S., Miraglia, L. J., Reyes, T. M., Rudic, R. D., McNamara, P., Naik, K. A., FitzGerald, G. A., Kay, S. A., & Hogenesch, J. B. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.018 · Cited by 1,115
Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors
Rutter, J., Reick, M., Wu, L. C., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1060698 · Cited by 1,059
Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β
Cho, H., Zhao, X., Hatori, M., Yu, R. T., Barish, G. D., Lam, M. T., Chong, L.-W., DiTacchio, L., Atkins, A. R., Glass, C. K., et al. (2012) · Nature · doi:10.1038/nature11048 · Cited by 1,037
Diverse somatic mutation patterns and pathway alterations in human cancers
Kan, Z., Jaiswal, B. S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H. M., Yue, P., Haverty, P. M., Bourgon, R., Zheng, J., et al. (2010) · Nature · doi:10.1038/nature09208 · Cited by 1,027
AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation
Lamia, K. A., Sachdeva, U. M., DiTacchio, L., Williams, E. C., Alvarez, J. G., Egan, D. F., Vasquez, D. S., Juguilon, H., Panda, S., Shaw, R. J., et al. (2009) · Science · doi:10.1126/science.1172156 · Cited by 958
Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958
Influence of Metabolism on Epigenetics and Disease
Kaelin, W. G., & McKnight, S. L. (2013) · Cell · doi:10.1016/j.cell.2013.03.004 · Cited by 920
Circadian Regulator CLOCK Is a Histone Acetyltransferase
Doi, M., Hirayama, J., & Sassone-Corsi, P. (2006) · Cell · doi:10.1016/j.cell.2006.03.033 · Cited by 887
Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists
Solt, L. A., Wang, Y., Banerjee, S., Hughes, T., Kojetin, D. J., Lundasen, T., Shin, Y., Liu, J., Cameron, M. D., Noel, R., et al. (2012) · Nature · doi:10.1038/nature11030 · Cited by 831
Modulation of oestrogen receptor signalling by association with the activated dioxin receptor
Ohtake, F., Takeyama, K.-I., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., et al. (2003) · Nature · doi:10.1038/nature01606 · Cited by 798
Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., & Park, J.-W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.023 · Cited by 758
Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., & Zhao, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr218 · Cited by 748
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Koivunen, P., Lee, S., Duncan, C. G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J. A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012) · Nature · doi:10.1038/nature10898 · Cited by 727
Hewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y.-M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya, S., Gleadle, J. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200273200 · Cited by 719
The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor
Nguyen, L. P., & Bradfield, C. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7001965 · Cited by 709
Rev-erbα, a Heme Sensor That Coordinates Metabolic and Circadian Pathways
Yin, L., Wu, N., Curtin, J. C., Qatanani, M., Szwergold, N. R., Reid, R. A., Waitt, G. M., Parks, D. J., Pearce, K. H., Wisely, G. B., et al. (2007) · Science · doi:10.1126/science.1150179 · Cited by 707
Huntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697
The circadian clock: pacemaker and tumour suppressor
Fu, L., & Lee, C. C. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1072 · Cited by 678
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652
Transcriptional coactivator PGC-1α integrates the mammalian clock and energy metabolism
Liu, C., Li, S., Liu, T., Borjigin, J., & Lin, J. D. (2007) · Nature · doi:10.1038/nature05767 · Cited by 643
The NAD metabolome — a key determinant of cancer cell biology
Chiarugi, A., Dölle, C., Felici, R., & Ziegler, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3340 · Cited by 639
Benzo[ a ]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor
Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., & Ishikawa, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.779 · Cited by 633
Gery, S., Komatsu, N., Baldjyan, L., Yu, A., Koo, D., & Koeffler, H. P. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.038 · Cited by 630
SIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging
Chang, H.-C., & Guarente, L. (2013) · Cell · doi:10.1016/j.cell.2013.05.027 · Cited by 615
Circadian topology of metabolism
Bass, J. (2012) · Nature · doi:10.1038/nature11704 · Cited by 610
Crosstalk between components of circadian and metabolic cycles in mammals
Asher, G., & Schibler, U. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.006 · Cited by 601
The mammalian basic helix–loop–helix/PAS family of transcriptional regulators
Kewley, R. J., Whitelaw, M. L., & Chapman-Smith, A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00211-5 · Cited by 589
Self-citationDioxin receptor is a ligand-dependent E3 ubiquitin ligase
Ohtake, F., Baba, A., Takada, I., Okada, M., Iwasaki, K., Miki, H., Takahashi, S., Kouzmenko, A., Nohara, K., Chiba, T., et al. (2007) · Nature · doi:10.1038/nature05683 · Cited by 584
Genetics of Circadian Rhythms in Mammalian Model Organisms
Lowrey, P. L., & Takahashi, J. S. (2011) · Advances in Genetics · doi:10.1016/b978-0-12-387690-4.00006-4 · Cited by 575
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
Losman, J.-A., & Kaelin, W. G. (2013) · Genes & Development · doi:10.1101/gad.217406.113 · Cited by 570
Metabolism and cancer: the circadian clock connection
Sahar, S., & Sassone-Corsi, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2747 · Cited by 551
Siepka, S. M., Yoo, S.-H., Park, J., Song, W., Kumar, V., Hu, Y., Lee, C., & Takahashi, J. S. (2007) · Cell · doi:10.1016/j.cell.2007.04.030 · Cited by 537
CLOCK-mediated acetylation of BMAL1 controls circadian function
Hirayama, J., Sahar, S., Grimaldi, B., Tamaru, T., Takamatsu, K., Nakahata, Y., & Sassone-Corsi, P. (2007) · Nature · doi:10.1038/nature06394 · Cited by 525
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
Sasaki, M., Knobbe, C. B., Munger, J. C., Lind, E. F., Brenner, D., Brüstle, A., Harris, I. S., Holmes, R., Wakeham, A., Haight, J., et al. (2012) · Nature · doi:10.1038/nature11323 · Cited by 513
Busino, L., Bassermann, F., Maiolica, A., Lee, C., Nolan, P. M., Godinho, S. I. H., Draetta, G. F., & Pagano, M. (2007) · Science · doi:10.1126/science.1141194 · Cited by 508
Identification of Small Molecule Activators of Cryptochrome
Hirota, T., Lee, J. W., St. John, P. C., Sawa, M., Iwaisako, K., Noguchi, T., Pongsawakul, P. Y., Sonntag, T., Welsh, D. K., Brenner, D. A., et al. (2012) · Science · doi:10.1126/science.1223710 · Cited by 499
Cuzick, J., Sestak, I., Bonanni, B., Costantino, J. P., Cummings, S., DeCensi, A., Dowsett, M., Forbes, J. F., Ford, L., LaCroix, A. Z., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60140-3 · Cited by 495
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
Xu, J., Wu, R.-C., & O'Malley, B. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2695 · Cited by 488
Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1
Dioum, E. M., Chen, R., Alexander, M. S., Zhang, Q., Hogg, R. T., Gerard, R. D., & Garcia, J. A. (2009) · Science · doi:10.1126/science.1169956 · Cited by 472
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger
Wang, G. G., Song, J., Wang, Z., Dormann, H. L., Casadio, F., Li, H., Luo, J.-L., Patel, D. J., & Allis, C. D. (2009) · Nature · doi:10.1038/nature08036 · Cited by 438
Deregulated expression of the PER1 , PER2 and PER3 genes in breast cancers
Chen, S.-T., Choo, K.-B., Hou, M.-F., Yeh, K.-T., Kuo, S.-J., & Chang, J.-G. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi075 · Cited by 423
Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka, H., & Poellinger, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.402-415.2000 · Cited by 385
Makino, Y., Kanopka, A., Wilson, W. J., Tanaka, H., & Poellinger, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200328200 · Cited by 375
Torres-Arzayus, M. I., de Mora, J. F., Yuan, J., Vazquez, F., Bronson, R., Rue, M., Sellers, W. R., & Brown, M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.027 · Cited by 375
Mammalian Per-Arnt-Sim Proteins in Environmental Adaptation
McIntosh, B. E., Hogenesch, J. B., & Bradfield, C. A. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135922 · Cited by 352
Crystal Structure of the Heterodimeric CLOCK:BMAL1 Transcriptional Activator Complex
Huang, N., Chelliah, Y., Shan, Y., Taylor, C. A., Yoo, S.-H., Partch, C., Green, C. B., Zhang, H., & Takahashi, J. S. (2012) · Science · doi:10.1126/science.1222804 · Cited by 349
Yoo, S.-H., Mohawk, J. A., Siepka, S. M., Shan, Y., Huh, S. K., Hong, H.-K., Kornblum, I., Kumar, V., Koike, N., Xu, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.055 · Cited by 340
Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding
Asher, G., Reinke, H., Altmeyer, M., Gutierrez-Arcelus, M., Hottiger, M. O., & Schibler, U. (2010) · Cell · doi:10.1016/j.cell.2010.08.016 · Cited by 340
Liao, D., Corle, C., Seagroves, T. N., & Johnson, R. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2701 · Cited by 339
The circadian molecular clock creates epidermal stem cell heterogeneity
Janich, P., Pascual, G., Merlos-Suárez, A., Batlle, E., Ripperger, J., Albrecht, U., Cheng, H.-Y. M., Obrietan, K., Di Croce, L., & Benitah, S. A. (2011) · Nature · doi:10.1038/nature10649 · Cited by 326
Michaud, J. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.14.1465 · Cited by 326
An oxygen-regulated switch in the protein synthesis machinery
Uniacke, J., Holterman, C. E., Lachance, G., Franovic, A., Jacob, M. D., Fabian, M. R., Payette, J., Holcik, M., Pause, A., & Lee, S. (2012) · Nature · doi:10.1038/nature11055 · Cited by 319
Halavaty, A. S., & Moffat, K. (2007) · Biochemistry · doi:10.1021/bi701543e · Cited by 317
Allosteric inhibition of hypoxia inducible factor-2 with small molecules
Scheuermann, T. H., Li, Q., Ma, H.-W., Key, J., Zhang, L., Chen, R., Garcia, J. A., Naidoo, J., Longgood, J., Frantz, D. E., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1185 · Cited by 315
A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors
Andersson, P., McGuire, J., Rubio, C., Gradin, K., Whitelaw, M. L., Pettersson, S., Hanberg, A., & Poellinger, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152706299 · Cited by 310
Self-citationNpas4 Regulates a Transcriptional Program in CA3 Required for Contextual Memory Formation
Ramamoorthi, K., Fropf, R., Belfort, G. M., Fitzmaurice, H. L., McKinney, R. M., Neve, R. L., Otto, T., & Lin, Y. (2011) · Science · doi:10.1126/science.1208049 · Cited by 301
Artificial ligand binding within the HIF2α PAS-B domain of the HIF2 transcription factor
Scheuermann, T. H., Tomchick, D. R., Machius, M., Guo, Y., Bruick, R. K., & Gardner, K. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808092106 · Cited by 301
Sasaki, M., Knobbe, C. B., Itsumi, M., Elia, A. J., Harris, I. S., Chio, I. I. C., Cairns, R. A., McCracken, S., Wakeham, A., Haight, J., et al. (2012) · Genes & Development · doi:10.1101/gad.198200.112 · Cited by 296
Shirogane, T., Jin, J., Ang, X. L., & Harper, J. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502862200 · Cited by 293
Disrupting Circadian Homeostasis of Sympathetic Signaling Promotes Tumor Development in Mice
Lee, S., Donehower, L. A., Herron, A. J., Moore, D. D., & Fu, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010995 · Cited by 286
A Novel Fusion Between MOZ and the Nuclear Receptor Coactivator TIF2 in Acute Myeloid Leukemia
Carapeti, M., Aguiar, R. C. T., Goldman, J. M., & Cross, N. C. P. (1998) · Blood · doi:10.1182/blood.v91.9.3127 · Cited by 272
Gorbacheva, V. Y., Kondratov, R. V., Zhang, R., Cherukuri, S., Gudkov, A. V., Takahashi, J. S., & Antoch, M. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409897102 · Cited by 270
Kawajiri, K., Kobayashi, Y., Ohtake, F., Ikuta, T., Matsushima, Y., Mimura, J., Pettersson, S., Pollenz, R. S., Sakaki, T., Hirokawa, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902132106 · Cited by 265
Geyfman, M., Kumar, V., Liu, Q., Ruiz, R., Gordon, W., Espitia, F., Cam, E., Millar, S. E., Smyth, P., Ihler, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209592109 · Cited by 251
Kang, T.-H., Lindsey-Boltz, L. A., Reardon, J. T., & Sancar, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915085107 · Cited by 250
Hirota, T., Lee, J. W., Lewis, W. G., Zhang, E. E., Breton, G., Liu, X., Garcia, M., Peters, E. C., Etchegaray, J.-P., Traver, D., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000559 · Cited by 247
Geng, C., He, B., Xu, L., Barbieri, C. E., Eedunuri, V. K., Chew, S. A., Zimmermann, M., Bond, R., Shou, J., Li, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304502110 · Cited by 246
Histone Lysine Demethylase JARID1a Activates CLOCK-BMAL1 and Influences the Circadian Clock
DiTacchio, L., Le, H. D., Vollmers, C., Hatori, M., Witcher, M., Secombe, J., & Panda, S. (2011) · Science · doi:10.1126/science.1206022 · Cited by 244
Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes
Belandia, B. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf412 · Cited by 242
Bautista, S., Valles, H., Walker, R. L., Anzick, S. L., Zeillinger, R., Meltzer, P. S., & Theillet, C. G. (1998) · PubMed · Cited by 231
Erbel, P. J. A., Card, P. B., Karakuzu, O., Bruick, R. K., & Gardner, K. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2533374100 · Cited by 228
A Constitutively Active Dioxin/Aryl Hydrocarbon Receptor Promotes Hepatocarcinogenesis in Mice
Moennikes, O., Loeppen, S., Buchmann, A., Andersson, P., Ittrich, C., Poellinger, L., & Schwarz, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0875 · Cited by 228
Deguchi, K., Ayton, P. M., Carapeti, M., Kutok, J. L., Snyder, C. S., Williams, I. R., Cross, N. C. P., Glass, C. K., Cleary, M. L., & Gilliland, D. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00051-5 · Cited by 225
Beischlag, T. V., Wang, S., Rose, D. W., Torchia, J., Reisz-Porszasz, S., Muhammad, K., Nelson, W. E., Probst, M. R., Rosenfeld, M. G., & Hankinson, O. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4319-4333.2002 · Cited by 223
Roles of the human hypoxia-inducible factor (HIF)-3α variants in the hypoxia response
Heikkilä, M., Pasanen, A., Kivirikko, K. I., & Myllyharju, J. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0679-5 · Cited by 213
Targeting the hypoxia-inducible factor (HIF) pathway in cancer
Poon, E., Harris, A. L., & Ashcroft, M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001173 · Cited by 213
Circadian oscillation of nucleotide excision repair in mammalian brain
Kang, T.-H., Reardon, J. T., Kemp, M., & Sancar, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812638106 · Cited by 205
Bouras, T., Southey, M. C., & Venter, D. J. (2001) · PubMed · Cited by 196
Loss of cryptochrome reduces cancer risk in p53 mutant mice
Ozturk, N., Lee, J. H., Gaddameedhi, S., & Sancar, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813028106 · Cited by 191
Chen, Z., Yoo, S.-H., Park, Y.-S., Kim, K.-H., Wei, S., Buhr, E., Ye, Z.-Y., Pan, H.-L., & Takahashi, J. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118034108 · Cited by 188
Miranda, E., Nordgren, I. K., Male, A. L., Lawrence, C. E., Hoakwie, F., Cuda, F., Court, W., Fox, K. R., Townsend, P. A., Packham, G. K., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja402993u · Cited by 185
Arredouani, M. S., Lu, B., Bhasin, M., Eljanne, M., Yue, W., Mosquera, J.-M., Bubley, G. J., Li, V., Rubin, M. A., Libermann, T. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0911 · Cited by 184
Kuang, S.-Q., Liao, L., Zhang, H., Lee, A. V., O’Malley, B. W., & Xu, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3745 · Cited by 182
Period 2 Mutation Accelerates ApcMin/+ Tumorigenesis
Wood, P. A., Yang, X., Taber, A., Oh, E.-Y., Ansell, C., Ayers, S. E., Al-Assaad, Z., Carnevale, K., Berger, F. G., Peña, M. M. O., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0196 · Cited by 180
The Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis
Fan, Y., Boivin, G. P., Knudsen, E. S., Nebert, D. W., Xia, Y., & Puga, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3090 · Cited by 177
Keith, B., Adelman, D. M., & Simon, M. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121494298 · Cited by 166
Johnson, A. B., & O’Malley, B. W. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.04.021 · Cited by 164
Kaelin, W. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010975 · Cited by 161
The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase
Pollard, P., Wortham, N., & Tomlinson, I. (2003) · Annals of Medicine · doi:10.1080/07853890310018458 · Cited by 159
Hwang-Verslues, W. W., Chang, P.-H., Jeng, Y.-M., Kuo, W.-H., Chiang, P.-H., Chang, Y.-C., Hsieh, T.-H., Su, F.-Y., Lin, L.-C., Abbondante, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222684110 · Cited by 159
Ema, M., Morita, M., Ikawa, S., Tanaka, M., Matsuda, Y., Gotoh, O., Saijoh, Y., Fujii, H., Hamada, H., Kikuchi, Y., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5865 · Cited by 157
Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor
Shin, J. H., Zhang, L., Murillo-Sauca, O., Kim, J., Kohrt, H. E. K., Bui, J. D., & Sunwoo, J. B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302856110 · Cited by 148
The phosphorylation status of PAS‐B distinguishes HIF‐1α from HIF‐2α in NBS1 repression
To, K. K. W., Sedelnikova, O. A., Samons, M., Bonner, W. M., & Huang, E. L. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601369 · Cited by 143
Liang, J., Prouty, L., Williams, B. J., Dayton, M. A., & Blanchard, K. L. (1998) · Blood · doi:10.1182/blood.v92.6.2118 · Cited by 141
Kim, J. H., Li, H., & Stallcup, M. R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00450-7 · Cited by 140
Kumar, M. B., & Perdew, G. H. (1999) · Europe PMC (PubMed Central) · Cited by 140
Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene
van Zutven, L. J. C. M., Önen, E., Velthuizen, S. C. J. M., van Drunen, E., von Bergh, A. R. M., van den Heuvel‐Eibrink, M. M., Veronese, A., Mecucci, C., Negrini, M., de Greef, G. E., et al. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20308 · Cited by 136
Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase
Zhou, X., Sun, H., Chen, H., Zavadil, J., Kluz, T., Arita, A., & Costa, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2942 · Cited by 134
HIF-2α deletion promotes Kras-driven lung tumor development
Mazumdar, J., Hickey, M. M., Pant, D. K., Durham, A. C., Sweet-Cordero, A., Vachani, A., Jacks, T., Chodosh, L. A., Kissil, J. L., Simon, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001296107 · Cited by 130
Fleming, F. J., Myers, E. A., Kelly, G., Crotty, T. B., McDermott, E. W. M., O’Higgins, N. J., Hill, A. D. K., & Young, L. S. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.016733 · Cited by 129
Wang, S., Yuan, Y., Liao, L., Kuang, S.-Q., Tien, J. C.-Y., O'Malley, B. W., & Xu, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808703105 · Cited by 122
Pongratz, I., Antonsson, C., Whitelaw, M. L., & Poellinger, L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4079 · Cited by 121
Self-citationYan, J., Erdem, H., Li, R., Cai, Y., Ayala, G., Ittmann, M., Yu‐Lee, L., Tsai, S. Y., & Tsai, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0955 · Cited by 117
Kuang, S.-Q., Liao, L., Wang, S., Medina, D., O'Malley, B. W., & Xu, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1179 · Cited by 110
Definition of a Dioxin Receptor Mutant That Is a Constitutive Activator of Transcription
McGuire, J., Okamoto, K., Whitelaw, M. L., Tanaka, H., & Poellinger, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105607200 · Cited by 102
Self-citationSmall molecule modifiers of circadian clocks
Chen, Z., Yoo, S.-H., & Takahashi, J. S. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1207-y · Cited by 102
Chrast, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.12.1853 · Cited by 102
Reiter, R., Wellstein, A., & Riegel, A. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104744200 · Cited by 100
Fereshteh, M. P., Tilli, M. T., Kim, S. E., Xu, J., O'Malley, B. W., Wellstein, A., Furth, P. A., & Riegel, A. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6702 · Cited by 97
Long, Q., Johnson, B. A., Osunkoya, A. O., Lai, Y., Zhou, W., Abramovitz, M., Xia, M., Bouzyk, M., Nam, R. K., Sugar, L., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.008 · Cited by 97
Furness, S. G. B., Lees, M. J., & Whitelaw, M. L. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.011 · Cited by 95
Self-citationRazeto, A., Ramakrishnan, V., Litterst, C. M., Giller, K., Griesinger, C., Carlomagno, T., Lakomek, N., Heimburg, T., Lodrini, M., Pfitzner, E., et al. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.057 · Cited by 92
Differential Activities of Murine Single Minded 1 (SIM1) and SIM2 on a Hypoxic Response Element
Woods, S. L., & Whitelaw, M. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110752200 · Cited by 88
Self-citationLee, S., Kim, H., Kim, J. W., & Lee, J. W. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.11.0365 · Cited by 88
Laffin, B., Wellberg, E. A., Kwak, H., Burghardt, R. C., Metz, R. P., Gustafson, T. L., Schedin, P. S., & Porter, W. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01701-07 · Cited by 85
New Aryl Hydrocarbon Receptor Homology Model Targeted To Improve Docking Reliability
Motto, I., Bordogna, A., Soshilov, A. A., Denison, M. S., & Bonati, L. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2001617 · Cited by 80
Sim2 Contributes to Neuroendocrine Hormone Gene Expression in the Anterior Hypothalamus
Goshu, E., Jin, H., Lovejoy, J., Marion, J.-F., Michaud, J. L., & Fan, C. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0372 · Cited by 79
Kucera, N., Schmalen, I., Hennig, S., Öllinger, R., Strauss, H. M., Grudziecki, A., Wieczorek, C., Kramer, A., & Wolf, E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113280109 · Cited by 74
A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer
O’Donnell, K. A., Keng, V. W., York, B., Reineke, E. L., Seo, D., Fan, D., Silverstein, K. A. T., Schrum, C. T., Xie, W., Mularoni, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115433109 · Cited by 72
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
Lee, J. H., & Sancar, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106284108 · Cited by 70
Cancer Therapeutic Agents Targeting Hypoxia-Inducible Factor-1
Wang, R., Zhou, S., & Li, S. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391606 · Cited by 68
Partch, C. L., & Gardner, K. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101357108 · Cited by 65
Increased Expression of SIM2-s Protein Is a Novel Marker of Aggressive Prostate Cancer
HALVORSEN, O. J., Rostad, K., Oyan, A. M., Puntervoll, H. E., Bø, T. H., Stordrange, L., Olsen, S., Haukaas, S. A., Hood, L., Jonassen, I., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1207 · Cited by 63
ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice
Ikuta, T., Kobayashi, Y., Kitazawa, M., Shiizaki, K., Itano, N., Noda, T., Pettersson, S., Poellinger, L., Fujii-Kuriyama, Y., Taniguchi, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt083 · Cited by 63
AHR signaling in prostate growth, morphogenesis, and disease
Vezina, C. M., Lin, T.-M., & Peterson, R. E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.039 · Cited by 55
Reiter, R., Oh, A. S., Wellstein, A., & Riegel, A. T. (2003) · Oncogene · doi:10.1038/sj.onc.1207202 · Cited by 51
Identification of residues in the N-terminal PAS domains important for dimerization of Arnt and AhR
Hao, N., Whitelaw, M. L., Shearwin, K. E., Dodd, I. B., & Chapman-Smith, A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1336 · Cited by 51
Self-citationRoles of Coactivators in Hypoxic Induction of the Erythropoietin Gene
Wang, F., Zhang, R., Wu, X., & Hankinson, O. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010002 · Cited by 50
Aleman, M. J., DeYoung, M. P., Tress, M., Keating, P., Perry, G. W., & Narayanan, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505484102 · Cited by 49
DeYoung, M. P., Tress, M., & Narayanan, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831000100 · Cited by 49
Farrall, A. L., & Whitelaw, M. L. (2009) · Oncogene · doi:10.1038/onc.2009.228 · Cited by 48
Self-citationFritz, W. A., Lin, T., & Peterson, R. E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn069 · Cited by 48
Guo, Y., Partch, C. L., Key, J., Card, P. B., Pashkov, V., Patel, A., Bruick, R. K., Wurdak, H., & Gardner, K. H. (2013) · ACS Chemical Biology · doi:10.1021/cb300604u · Cited by 47
Oshima, M., Mimura, J., Sekine, H., Okawa, H., & Fujii‐Kuriyama, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808694200 · Cited by 43
Havis, E., Coumailleau, P., Bonnet, A., Bismuth, K., Bonnin, M.-A., Johnson, R. L., Fan, C.-M., Relaix, F., Shi, D., & Duprez, D. (2012) · Development · doi:10.1242/dev.072561 · Cited by 38
Hao, N., Bhakti, V. L. D., Peet, D. J., & Whitelaw, M. L. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt206 · Cited by 37
Self-citationDifferential Transcriptional Regulation by Mouse Single-minded 2s
Metz, R. P., Kwak, H.-I., Gustafson, T., Laffin, B., & Porter, W. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508858200 · Cited by 36
Hao, N., Lee, K. L., Furness, S. G. B., Bosdotter, C., Poellinger, L., & Whitelaw, M. L. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.078873 · Cited by 35
Self-citationRegulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s)
Scribner, K. C., Behbod, F., & Porter, W. W. (2012) · Oncogene · doi:10.1038/onc.2012.286 · Cited by 34
Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy target
DeYoung, M. P., Tress, M., & Narayanan, R. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00409-9 · Cited by 31
Why Does ARNT2 Behave Differently from ARNT?
Hankinson, O. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn032 · Cited by 30
Scribner, K. C., Wellberg, E. A., Metz, R. P., & Porter, W. W. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0423 · Cited by 30
The bHLH/PAS transcription factor singleminded 2s promotes mammary gland lactogenic differentiation
Wellberg, E. A., Metz, R. P., Parker, C., & Porter, W. W. (2010) · Development · doi:10.1242/dev.041657 · Cited by 28
Structure of an Enclosed Dimer Formed by the Drosophila Period Protein
King, H. A., Hoelz, A., Crane, B. R., & Young, M. W. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.08.048 · Cited by 27
Okui, M., Yamaki, A., Takayanagi, A., Kudoh, J., Shimizu, N., & Shimizu, Y. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.05.018 · Cited by 24
Lodrini, M., Münz, T., Coudevylle, N., Griesinger, C., Becker, S., & Pfitzner, E. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn029 · Cited by 20
Cited by
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3846 · Cited by 883
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation
Hubbard, T. D., Murray, I. A., & Perdew, G. H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064246 · Cited by 640
Peek, C. B., Levine, D. C., Cedernaes, J., Taguchi, A., Kobayashi, Y., Tsai, S. J., Bonar, N. A., McNulty, M. R., Ramsey, K. M., & Bass, J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.010 · Cited by 409
The role of hypoxia-inducible factors in metabolic diseases
Gonzalez, F. J., Xie, C., & Jiang, C. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0096-z · Cited by 407
Metadata
- Authors
- Bersten, D. C., Sullivan, A. E., Peet, D. J., & Whitelaw, M. L.
- Affiliations
- The University of Adelaide (AU)
- Corresponding author
- Whitelaw, Murray L.
- Venue
- Nature Reviews Cancer
- Published
- 2013-11-22
- Volume
- 13
- Issue
- 12
- Pages
- 827-841
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2011946509
- Cited by
- 267
- References
- 181
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 25 · 2023: 27 · 2022: 25 · 2021: 26 · 2020: 20 · 2019: 17 · 2018: 28 · 2017: 20 · 2016: 19 · 2015: 12 · 2014: 12
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- bHLH-PAS proteins, helix-loop-helix transcription factors, PAS domain, heterodimeric transcription factors, oncometabolites, cancer metabolism, hypoxia signaling, circadian rhythm, environmental pollutants, protein structure, drug discovery
- MeSH terms
- Animals, Circadian Rhythm, Humans, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Basic Helix-Loop-Helix Proteins, CLOCK Proteins, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.